Ameritas Investment Partners, Inc. Evelo Biosciences, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.46 - $3.55 $3,476 - $8,452	-2,381 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$9.43 - $16.6 $6,534 - $11,503	693 Added 41.05%	2,381 $33,000
Q1 2021 May 14, 2021	BUY	$9.71 - $18.6 $5,389 - $10,323	555 Added 48.98%	1,688 $18,000
Q1 2019 May 15, 2019	BUY	$7.5 - $15.31 $5,700 - $11,635	760 Added 203.75%	1,133 $9,000
Q2 2018 Aug 13, 2018	BUY	$11.39 - $16.26 $4,248 - $6,064	373 New	373 $4,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.